The largest database of trusted experimental protocols

Aav2 gfp

Manufactured by Vector Biolabs
Sourced in United States

AAV2-GFP is a recombinant adeno-associated virus (AAV) vector containing the green fluorescent protein (GFP) gene. It is designed for gene delivery and expression studies.

Automatically generated - may contain errors

Lab products found in correlation

9 protocols using aav2 gfp

1

AAV-Mediated Overexpression of KLF7

Check if the same lab product or an alternative is used in the 5 most similar protocols
The AAV-GFP virus contained both AAV serotype 2 capsid and expressed GFP. GFP expression which was expressed under the control of the cytomegalovirus (CMV) immediate-early promoter (AAV2-GFP, 1.0 × 1013 viral particles/ml; Vector BioLabs, Philadelphia, USA) was used as a control. Mouse KLF7 was subcloned into an AAV2 vector cassette under the control of the CMV (AAV-m-KLF7; Vector BioLabs, Philadelphia, USA).
+ Open protocol
+ Expand
2

Optic Nerve Labeling in Ank3 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
AAV2-Cre-GFP or AAV2-GFP (Vector Biolabs) was injected into the eyes of P21 Ank3F/F mice using a pulled glass needle. Both Cre and GFP were driven by their own CMV promoters. The optic nerves were dissected 2 months after virus injection, followed by immunostaining.
+ Open protocol
+ Expand
3

Viral-Mediated Fmr1 Knockdown in NAc

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anesthetized floxed-Fmr1 mice received either AAV2-GFP or AAV2-CRE-GFP (1 uL/hemisphere; Vector Biolabs, Philadelphia, PA) bilaterally to the NAc (D/L −4.4, M/L +1.5, A/P +1.6). CPP began 20–21 days after surgery (Fig. 3B).
+ Open protocol
+ Expand
4

AAV-mediated gene delivery to VMH

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adeno-associated virus (AAV) vectors expressing Cre-GFP (category no. 7016, AAV2-Cre-GFP), Lin28a-GFP (AAV2-CMV-GFP-CMV-mLin28a, customized virus), and GFP (category no. 7004, AAV2-GFP) were purchased from Vector Biolabs and injected bilaterally into the VMH (coordinates, bregma: anterior-posterior, −1.5 mm; lateral, ±0.4 mm; and dorsal-ventral, −5.8 mm) at a rate of 40 nL/min (∼1 × 1012 viral particles/mL) for 15 min, and the injector remained in place for an additional 5 min before removal.
+ Open protocol
+ Expand
5

Targeted Cre expression in VTA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult male and female floxed Gabrd and Gabrg2 mice were stereotaxically injected with either AAV2-GFP or AAV2-Cre-GFP (Vector Biolabs) into the VTA using the following coordinates: A/P −3.6 mm, M/L ±0.5 mm, D/V 4.5 mm. This approach results in expression of GFP or Cre recombinase in a subset of neurons in the VTA.
+ Open protocol
+ Expand
6

Stereotaxic Viral Vector Delivery to Dorsal Hippocampus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice were anesthetized by intraperitoneal (i.p.) injection of a ketamine-xylazine mixture (100 mg/kg ketamine, 10 mg/kg xylazine). AAV2-GFP (Vector BioLabs #7004), AAV8-hSyn-DIO-hM3D(Gq)-mCherry (UNC Vectore Core), AAV8-hSyn-DIO-hM4D(Gi)-mCherry (UNC Vector Core), or AAV-FLEX-DTA (CMV-β-globin-DIO-mCherry-DTA-hGH pA generated by Dr. Patrick M. Fuller, Harvard Medical School) was stereotaxically injected into the dorsal hippocampus of each hemisphere (500 nL; posterior 2.0mm, lateral 1.5mm, depth 1.5mm) and the syringe was left in place for 5 minutes before withdrawal. For the EEG studies, mice were outfitted with an EEG/EMG headmount (Pinnacle #8201) utilizing stainless steel screws as two EEG leads, a reference electrode, EMG leads, and an animal ground. All animals were treated with buprenorphine (0.5mg/kg) preoperatively and then administered as needed to alleviate pain and/or distress to the animals during the three day postoperative observation period. Posthoc analysis was performed for each experiment to validate targeting and verify expected manipulations.
+ Open protocol
+ Expand
7

Optic Nerve Labeling in Ank3 Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
AAV2-Cre-GFP or AAV2-GFP (Vector Biolabs) was injected into the eyes of P21 Ank3F/F mice using a pulled glass needle. Both Cre and GFP were driven by their own CMV promoters. The optic nerves were dissected 2 months after virus injection, followed by immunostaining.
+ Open protocol
+ Expand
8

AAV2-GFP Production and Delivery

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant adeno-associated virus 2 carrying eGFP (AAV2-GFP) with CMV-enhanced chicken b-actin (CAG) promoter was purchased from Vector Biolabs (Malvern, PA; stock #7072) or generated generated by helper virus-free system. 79 (link) 293T cells were grown to 70-80% confluence at which point they were transfected with two packaging plasmids using PEI (Polyethylenimine, linear, MW-25k, Warrington, PA): one carrying the AAV rep, cap genes and another helper plasmid carrying the adenovirus helper functions. Three days after transfection, the cell lysates and the supernatant were harvested and 40% PEG 8000 was added to precipitate crude virus for 2 h. The viruses were then purified by double-centrifugation with cesium chloride and the isolated virus was dialyzed in 0.1M PBS/5% sorbital overnight. AAV2-GFP was microinjected into a DRG using a micropipette pulled to a diameter of 0.05 mm and a nanoinjector (B203XVY Nanoliter 2000; World Precision Instruments, Sarasota, FL). For each injection, the micropipette was introduced 0.5 mm into the DRG and a total volume of AAV (1 mL/DRG) containing >1 3 10 13 GC/mL injected over a 10 min period. The glass needle was left in place for 5 min after each injection.
+ Open protocol
+ Expand
9

Adeno-Associated Virus Delivery of BDNF

Check if the same lab product or an alternative is used in the 5 most similar protocols
AAV1/2-IRES-CMV-BDNF-GFP (AAV-BDNF; 1 x 10 12 gc/ml) and AAV1/2-IRES-CMV-GFP (AAV-GFP; 1 x 10 12 gc/ml) were designed as described in [16] and were purchased from the University of North Carolina Viral Vector Core. AAV2-CMV-GFP-mBDNF (AAV2-BDNF; 7.7 x 10 12 gc/ml) and AAV2-CMV-GFP (AAV2-GFP; 1 x 10 13 gc/ml) were purchased from Vector Biolabs (Malverna, PA). AAV-DIO-Ef1a-BDNF-IRES-mCherry (AAV-DIO-BDNF-mCherry; 1 x 10 12 gc/ml) and AAV-DIO-Ef1a -mCherry (AAV-DIO-mCherry; 1 x 10 12 gc/ml) were constructed in conjunction with C&M Biolabs
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!